Pfizer Notes Doctor Decisions In Appeal Of $142M RICO Award

Law360, New York (February 7, 2013, 7:29 PM EST) -- Pfizer Inc. argued to the First Circuit on Wednesday that physicians' independent decisions to prescribe pain drug Neurontin for off-label uses should take the drugmaker off the hook for a $142 million jury award to HMO operator Kaiser Foundation Health Plan Inc.

Pfizer is seeking to overturn a jury's finding that it violated the Racketeer Influenced and Corrupt Organizations Act by fraudulently marketing Neurontin for off-label use. Kaiser contended that had it known Neurontin was not effective for the claimed off-label uses, it would not have...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.